Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-20-001421
Filing Date
2020-05-07
Accepted
2020-05-06 18:06:56
Documents
43
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 proteo_10k-123119.htm 10-K 535397
2 DESCRIPTION OF THE REGISTRANT SECURITIES REGISTERED proteo_ex0401.htm EX-4.1 13338
3 SUBSIDIARIES OF PROTEO, INC. proteo_ex021.htm EX-21 1107
4 CERTIFICATION proteo_ex3101.htm EX-31.1 7979
5 CERTIFICATION proteo_ex3102.htm EX-31.2 8148
6 CERTIFICATION proteo_ex032.htm EX-32 4113
  Complete submission text file 0001683168-20-001421.txt   1929762

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE pteo-20191231.xml EX-101.INS 219020
8 XBRL SCHEMA FILE pteo-20191231.xsd EX-101.SCH 17047
9 XBRL CALCULATION FILE pteo-20191231_cal.xml EX-101.CAL 36505
10 XBRL DEFINITION FILE pteo-20191231_def.xml EX-101.DEF 68072
11 XBRL LABEL FILE pteo-20191231_lab.xml EX-101.LAB 146196
12 XBRL PRESENTATION FILE pteo-20191231_pre.xml EX-101.PRE 118224
Mailing Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612
Business Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612 949-253-4616
PROTEO INC (Filer) CIK: 0001063104 (see all company filings)

EIN.: 880292249 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30728 | Film No.: 20853886
SIC: 2834 Pharmaceutical Preparations